Todd Bazemore - Jun 28, 2021 Form 4 Insider Report for Kala Pharmaceuticals, Inc. (KALA)

Role
CHIEF OPERATING OFFICER
Signature
/s/ Eric Trachtenberg, Attorney-in-Fact
Stock symbol
KALA
Transactions as of
Jun 28, 2021
Transactions value $
-$16,796
Form type
4
Date filed
6/29/2021, 05:25 PM
Next filing
Oct 28, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KALA Common Stock Sale -$16.8K -2.91K $5.77 $135K Jun 28, 2021 Direct F1, F2
holding KALA Common Stock 42 Jun 28, 2021 By son F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of the reporting person's restricted stock units granted on June 25, 2020.
F2 Includes 118,000 unvested RSUs.
F3 The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.